International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 8, Issue:7, July, 2019

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : /
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(7): 2656-2660

COPD and Intestinal Dysbiosis
R.S. Bayramova*, M.S. Novruzova, H.M. Aliyeva and J.X. Talibova
Azerbaijan Medical University, Department of Medical Microbiology and Immunology, Azerbaijan
*Corresponding author

By WHO forecasts, a further increase in the prevalence and mortality of COPD among people of working age is predicted, due to uncontrolled environmental pollution, a tobacco pandemic, an increase in the level of allergens and a genetic predisposition. In chronization and progression of COPD, there is a violation of cellular and humoral immunity, production of pro-inflammatory cytokines of phagocytic cell activity that contribute to the persistence of the inflammatory process in the lungs. Therefore, the study of the state of intestinal microflora in patients with COPD and the timely correction of impaired microbiocinosis is an important task that needs to be studied. Patients with COPD have a chronic inflammatory process in the bronchopulmonary system, accompanied by inhibition of the functional activity of neutrophils, which complicates the formation of humoral immunity and leads to a persistent course of the disease with frequent exacerbations. The revealed violations of COPD associated with intestinal dysbacteriosis indicate pronounced manifestations of secondary immunodeficiency. The obtained data allow us to recommend bacteriological and immunological examination of patients with COPD to identify immunological deficiencies with concomitant intestinal dysbiosis for the purpose of complex treatment with the use of immunocorrecting and probiotics.

Keywords: Chronic obstructive pulmonary, Secondary immunodeficiency, Inflammatory process, Chronization, Phagitosis activity, Normal intestinal microflora, Dysbiotic changes, Bifidus bacteria and lactobacilli, E.coli

Download this article as Download

How to cite this article:

Bayramova, R.S., M.S. Novruzova, H.M. Aliyeva and Talibova, J.X. 2019. COPD and Intestinal Dysbiosis.Int.J.Curr.Microbiol.App.Sci. 8(7): 2656-2660. doi:
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.